← Back to headlines
Imunon Aims for 80 OVATION 3 Patients, Extends Cash Runway to H2 2026
Imunon announced plans to target approximately 80 OVATION 3 patients within the next 12 months, with its cash runway now projected to extend into the second half of 2026.
31 Mar, 19:43 — 31 Mar, 19:43
Sources
Showing 1 of 1 sources
